BamSEC and AlphaSense Join Forces
Learn More

Iterum Therapeutics Plc – Indentures

OTC: ITRMF    
Share price (6/29/26): $0.05    
Market cap (6/29/26): $2.636 million

Indentures Filter

EX-4.1
from 8-K 20 pages Prefunded Ordinary Share Purchase Warrant Iterum Therapeutics plc
12/34/56
EX-4.20
from 10-K 16 pages Description of the Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
12/34/56
EX-4.19
from S-1/A 3 pages Iterum Therapeutics Plc Mr a Sample Iterum Therapeutics Plc Subscription Rights Certificate This Subscription Rights Offering (The “Rights Offering”) Expires at 5:00 P.M., Eastern Time, on August 6, 2024, Unless the Exercise Period Is Extended (Such Date and Time, as It May Be Extended, the “Expiration Date”)
12/34/56
EX-4.18
from S-1/A 21 pages Warrant Agent Agreement
12/34/56
EX-4.17
from S-1/A 21 pages Warrant Agent Agreement
12/34/56
EX-4.16
from S-1/A 13 pages Iterum Therapeutics Plc 5-Year Warrant to Purchase Ordinary Shares
12/34/56
EX-4.15
from S-1/A 13 pages Iterum Therapeutics Plc 1-Year Warrant to Purchase Ordinary Shares
12/34/56
EX-4.15
from 10-K 16 pages Description of the Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
12/34/56
EX-4
from 10-K 16 pages Description of the Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
12/34/56
EX-4.5
from S-3 8 pages Form of Subordinated Note
12/34/56
EX-4.4
from S-3 8 pages Form of Senior Note
12/34/56
EX-4.3
from S-3 61 pages Iterum Therapeutics Plc and Trustee Indenture Dated as of Subordinated Debt Securities
12/34/56
EX-4.2
from S-3 60 pages Iterum Therapeutics Plc and Trustee Indenture Dated as of Senior Debt Securities
12/34/56
EX-4.15
from 10-K 15 pages Description of the Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
12/34/56
EX-4.1
from 8-K 22 pages Placement Agent Ordinary Share Purchase Warrant Iterum Therapeutics Plc Warrant Shares: Initial Exercise Date: February 12, 2021
12/34/56
EX-4.1
from 8-K 22 pages Underwriter Ordinary Share Purchase Warrant Iterum Therapeutics Plc
12/34/56
EX-4.3
from 8-K 12 pages Placement Agent Ordinary Share Purchase Warrant Iterum Therapeutics Plc
12/34/56
EX-4.2
from 8-K 12 pages Pre-Funded Ordinary Share Purchase Warrant Iterum Therapeutics Plc
12/34/56
EX-4.1
from 8-K 12 pages Ordinary Share Purchase Warrant Iterum Therapeutics Plc
12/34/56
EX-4.12
from S-1/A 21 pages Placement Agent Ordinary Share Purchase Warrant Iterum Therapeutics Plc
12/34/56